Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6449272 | 0.79 | — | — | |
| SCHEMBL2710196 | 0.78 | — | — | |
| SCHEMBL4803671 | 0.76 | PLG (0.31) | — | |
| SCHEMBL4803677 | 0.76 | PLG (0.31) | — | |
| SCHEMBL30071412 | 0.75 | SIGMAR1 (0.45) | — | |
| SCHEMBL2707372 | 0.75 | — | — | |
| SCHEMBL4803680 | 0.75 | — | — | |
| SCHEMBL4803687 | 0.75 | — | — | |
| SCHEMBL25175734 | 0.73 | CYP1A2 (0.34) | CYP1A2 | |
| SCHEMBL28885571 | 0.71 | FFAR1 (0.35) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-115335358-B | Synthesis of Capsaicin Derivatives | 阿克西赫姆公司 | 2024-07-12 | — | — | CN | disclosed |
| US-11891351-B2 | Synthesis of capsaicin derivatives | AXICHEM AS (NO) | 2024-02-06 | — | — | US | disclosed |
| US-20230060251-A1 | SYNTHESIS OF CAPSAICIN DERIVATIVES | AXICHEM AS (NO) | 2023-03-02 | — | — | US | disclosed |
| EP-4121408-A1 | SYNTHESIS OF CAPSAICIN DERIVATIVES | Axichem AB (NO) | 2023-01-25 | — | — | EP | disclosed |
| CN-115335358-A | Synthesis of capsaicin derivatives | 阿克西赫姆公司 | 2022-11-11 | — | — | CN | disclosed |
| WO-2021187992-A1 | SYNTHESIS OF CAPSAICIN DERIVATIVES | AXICHEM AS (NO) | 2021-09-23 | — | — | WO | disclosed |
| CN-1056824-C | Improved synthesis of cyclopropylacetylene | MERCK & CO INC (US) | 2000-09-27 | — | — | CN | disclosed |
| CN-1169137-A | Improved synthesis of cyclopropylacetylene | MERCK & CO INC (US) | 1997-12-31 | — | — | CN | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11891351-B2 | Synthesis of capsaicin derivatives | TRPV1, TRPV6, HCAR3 | CYP1A2 1303/4885GRM5 1323/4885 |
| US-20230060251-A1 | SYNTHESIS OF CAPSAICIN DERIVATIVES | TRPV1, TRPV6, HCAR3 | CYP1A2 1303/4885GRM5 1323/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.